
DeNovo Ventures
Description
DeNovo Ventures is a specialized venture capital firm established in 2000, focusing exclusively on the medical device sector. Based in Saratoga, California, the firm was founded by a team of seasoned investors and experienced medical device entrepreneurs who sought to leverage their deep industry knowledge and operational expertise to identify and nurture innovative healthcare technologies. Their investment strategy is centered on early to growth-stage companies developing novel medical devices that address significant unmet clinical needs and have the potential for substantial market impact.
The firm is known for its hands-on approach, often providing strategic guidance, operational support, and access to their extensive network within the medical device industry. DeNovo Ventures has raised significant capital over its history, with its third fund, DeNovo Ventures III, L.P., closing at $250 million. This substantial capital base allows them to support portfolio companies through various stages of development, from product conceptualization and regulatory approval to commercialization and market expansion. They typically look for companies with strong intellectual property, clear clinical utility, and experienced management teams.
DeNovo Ventures has historically deployed capital across a diverse range of medical device sub-sectors, including cardiovascular, orthopedics, neurostimulation, and surgical tools. Their investment philosophy emphasizes long-term partnerships, aiming to build enduring value by helping companies navigate the complex landscape of medical device development and commercialization. With a total capital under management approaching $600 million across its three dedicated funds, the firm has established itself as a prominent and specialized investor in the highly regulated and capital-intensive medical device industry, contributing to the advancement of patient care through technological innovation.
Investor Profile
DeNovo Ventures has backed more than 86 startups, with 0 new investments in the last 12 months alone. The firm has led 11 rounds, about 13% of its total and boasts 24 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
- Typical check size: $3M – $10M.
Stage Focus
- Series B (23%)
- Series C (19%)
- Series D (15%)
- Series Unknown (15%)
- Series A (8%)
- Series E (7%)
- Series F (5%)
- Private Equity (3%)
- Debt Financing (2%)
- Post Ipo Equity (1%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Medical
- Health Diagnostics
- Therapeutics
- Pharmaceutical
- Manufacturing
- Biopharma
- Beauty
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.